Citation 60596

WILLSON,JKV: LONG,BH: CHAKRABARTY,S: BRATTAIN,DE: BRATTAIN,MG:. (1985). EFFECTS OF BMY 25282, A MITOMYCIN C ANALOGUE, IN MITOMYCIN C-RESISTANT HUMAN COLON CANCER CELLS.. 45(11)

Citation Details

Title	EFFECTS OF BMY 25282, A MITOMYCIN C ANALOGUE, IN MITOMYCIN C-RESISTANT HUMAN COLON CANCER CELLS.
Authors	WILLSON,JKV: LONG,BH: CHAKRABARTY,S: BRATTAIN,DE: BRATTAIN,MG:
Year	1985
Volume	45
Issue	11

Summary

Year: 1985

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	ACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	INACTIVE
7	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	INACTIVE
8	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C	INACTIVE
9	DNA CROSS-LINK FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	MITOMYCIN C	ACTIVE
10	DNA CROSS-LINK FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	MITOMYCIN C	ACTIVE
11	DNA CROSS-LINK FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	MITOMYCIN C	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C ANALOG BMY-25282	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C ANALOG BMY-25282	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C ANALOG BMY-25282	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C ANALOG BMY-25282	ACTIVE
5	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C ANALOG BMY-25282	ACTIVE
6	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C ANALOG BMY-25282	ACTIVE
7	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C ANALOG BMY-25282	ACTIVE
8	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MITOMYCIN C ANALOG BMY-25282	ACTIVE
9	DNA CROSS-LINK FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	MITOMYCIN C ANALOG BMY-25282	ACTIVE
10	DNA CROSS-LINK FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	MITOMYCIN C ANALOG BMY-25282	ACTIVE
11	DNA CROSS-LINK FORMATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	MITOMYCIN C ANALOG BMY-25282	ACTIVE

Show SPARQL Queries (1)